VYNE - VYNE Therapeutics Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.39 -0.01 (-1.28%)	0.0 (0.0%)	0.0 (0.0%)	0.0 (1.29%)	0.01 (2.59%)	-0.01 (-2.67%)	0.0 (0.03%)	0.0 (0.03%)

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.13
Diluted EPS:: -0.13
Basic P/E:: -2.9615
Diluted P/E:: -2.9615
RSI(14) 1m:: 100.0
VWAP:: 0.39
RVol:: 0.6211

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.39 -0.0 (-1.23%)	Oct 15 11:20
1m	Price increase 1m	0.39 +0.0 (+1.17%)	Oct 15 10:56
1m	Price increase 1m	0.39 +0.0 (+1.17%)	Oct 15 10:55
1m	Price increase 1m	0.39 +0.0 (+1.17%)	Oct 15 10:55
1m	Price increase 1m	0.39 +0.0 (+1.17%)	Oct 15 10:55